CIBC Private Wealth Group’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
DSCM
SFM
AC
SBH
CIBC Private Wealth Group's ANGO Position: Q2 2025 in Review
CIBC Private Wealth Group sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 684 shares — an estimated $6.16K sold.
CIBC Private Wealth Group first reported a position in ANGO in Q1 2025 and held it in 1 quarter. The position peaked at $6.16K in Q1 2025. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.
- CIBC Private Wealth Group reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
- CIBC Private Wealth Group sold 684 AngioDynamics shares in Q2 2025, an estimated $6.16K.
- CIBC Private Wealth Group first reported a position in AngioDynamics in Q1 2025 and held it in 1 quarter.
- CIBC Private Wealth Group's AngioDynamics position peaked at $6.16K in Q1 2025.
- 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.
Based on CIBC Private Wealth Group's 13F filing for Q2 2025, filed 12 Aug 2025.